Literature DB >> 22043569

Does previous abdominal operation affect peritoneal dialysis complications and outcomes?

Piyatida Chuengsaman1, Apichat Panomrerngsak, Kanda Sriudom.   

Abstract

OBJECTIVE: Peritoneal dialysis (PD) "First Policy" for end stage renal disease (ESRD) patients who are under universal healthcare coverage scheme, was implemented in Thailand since January 2008. Now there are about 10,000 PD patients all over the country and most of them are in low to medium socio-economic status. In the past, previous abdominal operation was considered as a contra-indication to PD. The purpose of the present study is to compare the complications and outcomes between patients with and without previous abdominal operation. MATERIAL AND
METHOD: The present study was a retrospective review of all new PD cases for complications and outcome of the first PD catheter implantation. The method of catheter implantation is mini-laparotomy under local anesthesia by one surgeon. The bleeding, exit site/wound infection, catheter malposition/obstruction, and catheter/technique/patient survival rate were compared between two groups.
RESULTS: In 730 ESRD patients who underwent catheter implantation, there were 106 patients with history of previous abdominal operation (14.5%). There were no significant differences between patients "with previous abdominal operation" and "without previous abdominal operation", for bleeding, exit site/wound infection, catheter malposition/obstruction, and catheter/technique/patient survival.
CONCLUSION: History of previous abdominal operation in ESRD patients is not a contra-indication to PD. The complications are low and the outcomes are excellent regardless of previous abdominal operation. Dedicated catheter implantation team might be the key of success.

Entities:  

Mesh:

Year:  2011        PMID: 22043569

Source DB:  PubMed          Journal:  J Med Assoc Thai        ISSN: 0125-2208


  1 in total

1.  The ideal position of the peritoneal dialysis catheter is not always ideal.

Authors:  Tatiana Tanasiychuk; Rafael Selgas; Daniel Kushnir; Muhammad Abd Elhalim; Alon Antebi; Gloria Del Peso; Maria A Bajo; Victor Frajewicki
Journal:  Int Urol Nephrol       Date:  2019-07-01       Impact factor: 2.370

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.